The Liver Meeting 2023-3063 Cirrhosis As a Multisystem Disorder

3063 Cirrhosis As a Multisystem Disorder - Part 2

Video Transcription

Video Summary

Dr. Elliot Tapper from the University of Michigan discusses the practical application of non-invasive tests in liver disease management. He emphasizes the importance of understanding the probability of liver disease progression rather than focusing solely on specific diagnostic stages. By tailoring non-invasive tests to individual patients and considering factors like age and risk factors, clinicians can better predict and prevent adverse outcomes. Dr. Tapper highlights the limitations of traditional methods like liver biopsy and advocates for a personalized approach using tools like FIB4 and elastography. He suggests a three-step process of assessing certainty, selecting appropriate tests, and implementing management based on risk assessment. Overall, his presentation stresses the need to balance confidence in test results with the clinical implications for each patient.

Keywords

non-invasive tests

liver disease management

probability of disease progression

personalized approach

FIB4 and elastography